Ambu A/S operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ambu A/S with three other
medical equipment manufacturers in Europe:
of UNITED KINGDOM
sales of £31.68 million [US$43.04 million]
of which 74%
was Human Healthcare),
Ypsomed Holding AG
(393.87 million Swiss Francs [US$442.05 million]
of which 49%
was Delivery Systems), and
Safe Orthopaedics SA
based in FRANCE
(3.84 million Euros [US$4.64 million]
During the year ended September of 2020, sales at
Ambu A/S were 3.57 billion Danish Kroner (US$579.25 million).
increase of 26.5%
versus 2019, when the company's sales were 2.82 billion Danish Kroner.
This was the fifth consecutive year of sales increases at Ambu A/S
(and since 2015, sales have increased a total of 89%).
Sales of Visualisation saw an increase
that was more than double the company's growth rate: sales were up
81.8% in 2020, from
941.00 million Danish Kroner to 1.71 billion Danish Kroner.
Not all segments of Ambu A/S experienced an increase in sales in 2020:
sales of Patient Monitoring and Diagnostics fell 10.4% to 796.00 million Danish Kroner.